Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA

Current Medical Research and Opinion

Volumn 26, Issue 8, 2010, Pages 1925-1932

  Heitmann, J ^a   Greulich, T ^a   Reinke, C ^a   Koehler, U ^a   Vogelmeier, C ^a   Becker, H F ^b   Schmidt, A C ^c   Canisius, S ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ASKLEPIOS HOSPITAL BARMBEK   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Beta adrenergic blockers; Hypertension; Sleep apnoea

Indexed keywords

NEBIVOLOL; PLACEBO; VALSARTAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART RATE; HUMAN; MALE; POLYSOMNOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLOW WAVE SLEEP; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZOPYRANS; BLOOD PRESSURE; ETHANOLAMINES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 77954736040     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.497326     Document Type: Article

References (39)

1. Wieber SJ. The cardiac consequences of the obstructive sleep apnea-hypopnea syndrome. Mt Sinai J Med 2005;72:10-12
2. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5
3. Bloch KE. Alternatives to CPAP in the treatment of the obstructive sleep apnea syndrome. Swiss Med Wkly 2006;136:261-7
4. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005;142:187-97
5. Pankow W, Nabe B, Lies A, et al. Influence of sleep apnea on 24-hour blood pressure. Chest 1997;112:1253-8
6. Ringler J, Basner RC, Shannon R, et al. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. J Appl Physiol 1990; 69:2143-8
7. Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001;24:721-5
8. Pelttari LH, Hietanen EK, Salo TT, et al. Little effect of ordinary antihyperten-sive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am J Hypertens 1998;11:272-9
9. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84
10. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73 (Pubitemid 36070935)
11. Boudoulas H, Schmidt H, Geleris P, et al. Case reports on deterioration of sleep apnea during therapy with propranolol-preliminary studies. Res Commun Chem Pathol Pharmacol 1983;39:3-10
12. Kraiczi H, Hedner J, Peker Y, et al. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161:1423-8
13. Mayer J, Weichler U, Herres-Mayer B, et al. Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J Cardiovasc Pharmacol 1990;16:952-61
14. Planes C, Foucher A, Leroy M, et al. Effect of celiprolol treatment in hypertensive patients with sleep apnea. Sleep 1999;22:507-13
15. McNeely W, Goa KL. Nebivolol in the management of essential hypertension: a review. Drugs 1999;57:633-51
16. Veverka A, Nuzum DS, Jolly JL. Nebivolol: a third-generation beta-adrenergic blocker. Ann Pharmacother 2006;40:1353-60
17. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-71
18. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000;55:1046-51
19. Taddei S, Virdis A, Ghiadoni L, et al. Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol 2001;38(Suppl. 2):S11-14
20. Danchin N, Genton P, Atlas P, et al. Comparative effects of atenolol and clonidine on polygraphically recorded sleep in hypertensive men: a randomized, double-blind, crossover study. Int J Clin Pharmacol Ther 1995;33:52-5
21. Rechtschaffen A, Kales A. A Manual of Standardized Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute, 1968
22. Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep 1997. 20. 406-22
23. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5
24. Black HR, Graff A, Shute D, et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril. J Hum Hypertens 1997;11:483-9
25. Hermida RC, Calvo C, Ayala DE, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int 2005;22:755-76
26. Fietze I, Quispe-Bravo S, Hansch T, et al. Arousals and sleep stages in patients with obstructive sleep apnoea syndrome: changes under nCPAP treatment. J Sleep Res 1997;6:128-33
27. Weichler U, Herres-Mayer B, Mayer J, et al. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1991; 78:124-30
28. Kantola I, Rauhala E, Erkinjuntti M, et al. Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol. J Cardiovasc Pharmacol 1991;18(Suppl. 3):S41-5
29. Yilmaz MB, Erdem A, Yalta K, et al. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol. Adv Ther 2008;25:871-83
30. Brismar K, Hylander B, Eliasson K, et al. Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand 1988;223:525-30
31. Stoschitzky K, Stoschitzky G, Brussee H, et al. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. Cardiology 2006;106:199-206
32. Tamura A, Kawano Y, Naono S, et al. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 2007;131:130-5
33. Holwerda NJ, Fogari R, Angeli P, et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril. J Hypertens 1996;14:1147-51
34. Van NL, Schelling A, Vertommen C, et al. Nebivolol vs enalapril in the treatment of essential hypertension: a double-blind randomised trial. J Hum Hypertens 1997;11:813-19
35. Loredo JS, ncoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens 2001;14:887-92
36. Stradling JR, Barbour C, Glennon J, et al. Which aspects of breathing during sleep influence the overnight fall of blood pressure in a community population? Thorax 2000;55:393-8
37. Lacourciere Y, Lefebvre J, Poirier L, et al. A double-blind crossover comparison of nebivolol and lisinopril in the treatment of ambulatory hypertension. Am J Ther 1994;1:74-80
38. Chediak AD, cevedo-Crespo JC, Seiden DJ, et al. Nightly variability in the indices of sleep-disordered breathing in men being evaluated for impotence with consecutive night polysomnograms. Sleep 1996;19:589-92
39. Le BO, Hoffmann G, Tecco J, et al. Mild to moderate sleep respiratory events: one negative night may not be enough. Chest 2000;118:353-9